Prothena presents TDP-43 data at neuroscience conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Prothena presents TDP-43 data at neuroscience conference
November 19, 2025 4:05 PM EST
TDP-43 CYTOPE® preclinical data demonstrates the potential of Prothenas CYTOPE technology as a novel modality for delivering large molecules into cells, enabling precise targeting of intracellular disease pathways
Systemically-administered TDP-43 CYTOPE rapidly and efficiently distributed to the brain and periphery, internalized into the cytosol and significantly reduced intracellular TDP-43 pathology in an ALS mouse model
TDP-43 CYTOPE meaningfully reduced intracellular TDP-43 pathology and associated RNA dysregulation caused by cryptic exon inclusions - key pathogenic features of TDP-43 proteinopathies - in a human-derived neuronal cell line
Â
DUBLIN, Ireland--(BUSINESS WIRE)--
Prothena... More
